Parallel Advisors, LLC Catalyst Biosciences, Inc. Transaction History

Parallel Advisors, LLC

  • $4.34 Billion
  • Q4 2024

A detailed history of Parallel Advisors, LLC transactions in Catalyst Biosciences, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 15 shares of CBIO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
N/A
15 New
15 $0

Others Institutions Holding CBIO

# of Institutions
2
Shares Held
230
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email